Yehia Hashad, MD, of Bausch + Lomb on patient safety for viewing the solar eclipse
March 29th 2024Yehia Hashad, executive vice president, research and development, and Chief Medical Officer at Bausch + Lomb sat down with David Hutton of Ophthalmology Times to talk about the upcoming solar eclipse and what ophthalmologists can do to promote safe viewing of the event for their patients.
Read More
Ophthalmology’s ‘moon shot’: Donation fast-tracking Bascom Palmer‘s whole eye transplant initiative
March 28th 2024The Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine recently received a $1 million donation to drive its efforts to successfully transplant a whole eye.
Read More
Terry Kim, MD, joining Alcon as chief medical officer and head of global medical safety
March 26th 2024According to Alcon, as CMO, Terry Kim, MD, will continue to integrate scientific and clinical priorities across Alcon’s Surgical and Vision Care franchises, with a focus on meeting the needs of patients and eye care practitioners across the globe.
Read More
RadiusXR publishes NOVA clinical trial results for virtual reality perimetry
March 26th 2024The NOVA clinical trial has found statistical non-inferiority to current clinical standards for sensitivities at individual test locations, glaucoma staging using Medicare definitions, and an exceptionally high correlation of 0.94 in mean deviation.
Read More
Diagnosis and management of solar retinopathy
March 21st 2024Solar retinopathy is caused by prolonged or high intensity exposure of the fovea centralis to light energy. Suspected cases of solar retinopathy may require urgent referral to an ophthalmologist for diagnosis, and to eliminate treatable causes for central visual disturbance.
Read More
Connecticut city official files lawsuit against ophthalmologist he claims damaged his vision
March 20th 2024In court documents in Connecticut Superior Court in Bridgeport, Isidore Sobkowski claims surgeons at the Wilton Surgery Center failed to properly clean their instruments resulting in him contracting a sight-threatening eye infection.
Read More
Nicox publishes results of Phase 3 trial of NCX 470 for treatment of glaucoma
March 20th 2024According to the company, NCX 470 is a novel NO-donating bimatoprost eye drop, is currently in Phase 3 clinical development for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.
Read More
Alfredo A. Sadun, MD, PhD, discusses research targeting LHON
Published: March 13th 2024 | Updated: June 4th 2024Scientists at the Doheny Eye Institute, in collaboration with UCLA chemists, demonstrate how a single gene mutation in an enzyme complex known to produce the energy required by cells causes a sudden, blinding disease.
Read More
Vermont legislators considering bill to expand scope of practice for optometrists
March 11th 2024Vermont is the latest state to consider legislation expanding the scope of practice for optometrists. Earlier this year, South Dakota became the 12th state to expand the scope of practice for optometrists.
Read More